biotechnology
3 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 25A233 | Agilent Technologies, Inc. v. Synthego Corp. | Federal Circuit | 2025-08-28 | Presumed Complete | biotechnology crispr federal-circuit patent-enablement prior-art research-and-development | Whether the Federal Circuit's presumption of enablement for prior art publications in unpredictable technological fields improperly undermines patent … | |
| 23-245 | ChromaDex, Inc., et al. v. Elysium Health, Inc. | Federal Circuit | 2023-09-14 | Denied | Response Waived | alice-mayo-framework alice-v-cls-bank biotechnology federal-circuit inventive-concept mayo-v-prometheus natural-phenomena patent-eligibility | Whether the two-step Alice/Mayo framework governs the eligibility of patents allegedly directed to natural phenomena |
| 18-127 | Amgen Inc., et al. v. Sanofi, et al. | Federal Circuit | 2018-07-27 | Denied | Amici (1)Response RequestedRelisted (2) | 35-usc-112 biotechnology enablement federal-circuit innovation patent-law possession statutory-interpretation written-description | Whether the standard for determining the adequacy of the 'written description of the invention' should be as the statute says—that the description mus… |